NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer
NKG2A是免疫治疗耐药的MHC-I异质性三阴性乳腺癌的治疗靶点
期刊:Cancer Discovery
影响因子:33.3
doi:10.1158/2159-8290.CD-23-0519
Taylor, Brandie C; Sun, Xiaopeng; Gonzalez-Ericsson, Paula I; Sanchez, Violeta; Sanders, Melinda E; Wescott, Elizabeth C; Opalenik, Susan R; Hanna, Ann; Chou, Shu-Ting; Van Kaer, Luc; Gomez, Henry; Isaacs, Claudine; Ballinger, Tarah J; Santa-Maria, Cesar A; Shah, Payal D; Dees, Elizabeth C; Lehmann, Brian D; Abramson, Vandana G; Pietenpol, Jennifer A; Balko, Justin M